Cyclobenzaprine Hydrochloride
Product Images NDC 10544-072

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 10544-072). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cyclobenzaprine HCL)

FDA Label Image

Label Graphic-cyclobenzaprine 10mg 15s (3d3179d3 E2f0 4d4f Aef6 Dc18b26fd4a7 02)

Label Graphic-cyclobenzaprine 10mg 15s (3d3179d3 E2f0 4d4f Aef6 Dc18b26fd4a7 02)
This is a description of Cyclobenzaprine Hydrochloride Tablets, USP 10mg, with NDC code 10544-072-15 and LCN# 000. The tablets come in 15 tablets per container and are only available with a prescription. Dosage information is provided on the package insert. The tablets should be kept in a controlled room temperature between 20°C to 25°C (68°F to 77°F) and stored in a moisture-resistant container out of the reach of children. The manufacturer is Pharmacal, Inc., located in North Blenheim, NY with Lot# BP00OO000D and Exp.Date: 00/00/0000. Watson Laboratories, Inc. packaged the tablets by Blen. There are four different lot numbers and expiration dates provided but no additional information on them.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.